Valuation Astellas Pharma Inc. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 15:59:55 2026-07-10 EDT			5-day change	1st Jan Change
13.25 ^USD	+0.45%		-0.38%	-0.30%

07-10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ
07-10	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	3,837,376	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-14.96%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	3,760,595	3,446,136	3,170,611
Change	-	-6.22%	-13.1%	23.8%	48.4%	-21.6%	-8.36%	-8%
P/E	28.5x	34.7x	173x	51x	15.5x	11.1x	11.8x	15.5x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	1.92x	1.8x	1.74x
PEG	-	-1.8x	-2.1x	0x	0x	0.6x	-2.1x	-0.6x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.71x	1.85x	2.09x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.67x	1.66x	1.73x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.84x	5.55x	6.25x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.23x	7.95x	9.67x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	8.93x	6.81x	7.07x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11.2%	14.7%	14.1%
Dividend per Share ²	50	60	70	74	78	80.46	82.77	84.92
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.76%	3.86%	3.96%
EPS ²	67.08	54.24	9.51	28.35	162.8	192.6	181.7	138.1
Distribution rate	74.5%	111%	736%	261%	47.9%	41.8%	45.5%	61.5%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,250,161	2,071,668	1,836,192
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	644,345	620,688	507,491
EBIT ¹	155,686	133,029	25,518	41,039	382,633	457,106	433,329	327,924
Net income ¹	124,086	98,714	17,045	50,747	291,535	344,595	324,743	246,434
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-76,782	-391,241	-666,766
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,142.00	2,142.00	2,142.00
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,791,492	-	-
Announcement Date	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.77x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	161B
Average	16.15x	6.44x	16.46x	2.44%	397.1B
Weighted average by Cap.	23.86x	7.85x	18.16x	2%